Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
All content for Can We End Epidemics? is the property of Foreign Policy and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
It’s not just infectious diseases that drive epidemics and pandemics; health inequalities can seriously stymie any progress. In this episode of Can We End Epidemics? host Henry Bonsu joins Oni Blackstock, a primary care and HIV physician and founder of the group Health Justice, Amanita Calderón-Cifuentes, an HIV research and advocacy officer for Transgender Europe, and Annemiek de Ruiter, ViiV Healthcare’s vice president and head of global medical sciences, to ask how poverty, racism, homophobia, transphobia, stigma, and all forms of discrimination, including criminalization, drive inadequate access to testing, prevention, treatment, and care, fueling epidemics. They discuss how policymakers, innovators, and community pioneers could address disparities by improving access to information, education, services, innovation, and health technologies for people and communities.
Glossary of terms used this season: https://foreignpolicy.com/podcasts/can-we-end-epidemics/
Can We End Epidemics?
Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
